Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 772

    1.

    Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.

    Cohen D, Stolk RP, Grobbee DE, Gispen-de Wied CC.

    Diabetes Care. 2006 Apr;29(4):786-91.PMID: 16567816 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

    Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins E, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC.

    Arch Gen Psychiatry. 2005 Jan;62(1):19-28.PMID: 15630069 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls?

    Sengupta S, Parrilla-Escobar MA, Klink R, Fathalli F, Ying Kin Ng, Stip E, Baptista T, Malla A, Joober R.

    Schizophr Res. 2008 Jul;102(1-3):329-36. Epub 2008 Apr 8.PMID: 18396386 [PubMed - indexed for MEDLINE]Related articles

    4.

    Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.

    van Winkel R, De Hert M, Wampers M, Van Eyck D, Hanssens L, Scheen A, Peuskens J.

    J Clin Psychiatry. 2008 Mar;69(3):472-9.PMID: 18348593 [PubMed - indexed for MEDLINE]Related articles

    5.

    Atypical antipsychotics and glucose homeostasis.

    Bergman RN, Ader M.

    J Clin Psychiatry. 2005 Apr;66(4):504-14. Review.PMID: 15816794 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Schizophrenia, diabetes mellitus and antipsychotics]

    Gury C.

    Encephale. 2004 Jul-Aug;30(4):382-91. Review. French. PMID: 15538314 [PubMed - indexed for MEDLINE]Related articles

    7.

    Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.

    Cohen D, Dekker JJ, Peen J, Gispen-de Wied CC.

    Eur Neuropsychopharmacol. 2006 Apr;16(3):187-94. Epub 2005 Nov 2.PMID: 16263247 [PubMed - indexed for MEDLINE]Related articles

    8.

    Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine.

    Yasui-Furukori N, Sato Y, Furukori H, Saito M, Nakagami T, Kaneko S.

    J Clin Psychiatry. 2009 Jan;70(1):95-100.PMID: 19026267 [PubMed - indexed for MEDLINE]Related articles

    9.

    Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.

    Utzschneider KM, Prigeon RL, Faulenbach MV, Tong J, Carr DB, Boyko EJ, Leonetti DL, McNeely MJ, Fujimoto WY, Kahn SE.

    Diabetes Care. 2009 Feb;32(2):335-41. Epub 2008 Oct 28. Erratum in: Diabetes Care. 2009 Jul;32(7):1355. PMID: 18957530 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients.

    Arranz B, Rosel P, Ramírez N, Dueñas R, Fernández P, Sanchez JM, Navarro MA, San L.

    J Clin Psychiatry. 2004 Oct;65(10):1335-42.PMID: 15491236 [PubMed - indexed for MEDLINE]Related articles

    12.

    Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.

    da Silva RC, Miranda WL, Chacra AR, Dib SA.

    J Diabetes Complications. 2007 Mar-Apr;21(2):84-92.PMID: 17331856 [PubMed - indexed for MEDLINE]Related articles

    14.

    Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia.

    Sernyak MJ, Gulanski B, Leslie DL, Rosenheck R.

    J Clin Psychiatry. 2003 May;64(5):605-8.PMID: 12755666 [PubMed - indexed for MEDLINE]Related articles

    16.

    Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

    Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR.

    Lancet. 2009 Jun 27;373(9682):2215-21. Epub 2009 Jun 8.PMID: 19515410 [PubMed - indexed for MEDLINE]Related articles

    17.

    Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia.

    Newcomer JW, Haupt DW, Fucetola R, Melson AK, Schweiger JA, Cooper BP, Selke G.

    Arch Gen Psychiatry. 2002 Apr;59(4):337-45. Review.PMID: 11926934 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

    Henderson DC, Copeland PM, Borba CP, Daley TB, Nguyen DD, Cagliero E, Evins AE, Zhang H, Hayden DL, Freudenreich O, Cather C, Schoenfeld DA, Goff DC.

    J Clin Psychiatry. 2006 May;67(5):789-97.PMID: 16841629 [PubMed - indexed for MEDLINE]Related articles

    19.

    What is a normal glucose value? Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose.

    Piché ME, Arcand-Bossé JF, Després JP, Pérusse L, Lemieux S, Weisnagel SJ.

    Diabetes Care. 2004 Oct;27(10):2470-7.PMID: 15451918 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.

    Lamberti JS, Costea GO, Olson D, Crilly JF, Maharaj K, Tu X, Groman A, Dietz MB, Bushey MP, Olivares T, Wiener K.

    J Clin Psychiatry. 2005 Jul;66(7):900-6.PMID: 16013906 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data